EXPLORE!

Oral Itraconazole for Treatment of Infantile Hemangiomas: Updated Clinical and Mechanism Research

  860 Views

Dr Yuping Ran, Chenglu, China    23 January 2019

  • The clinical efficacy of oral itraconazole is 71.05%.
  • It may cause mild, reversible diarrhea.
  • Down regulation of P13-AKT-mTOR and Hedgehog signalling pathways, inhibition of hemangioma cell growth.
  • Induces hemangioma endothelial cells autophagy and apoptosis.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.